Platelet-rich plasma improves pain and function in knee osteoarthritis: a retrospective study
Frontiers in Physiology · 29.10.2025 · 16
DOI: 10.3389/fphys.2025.1678037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Physiology, online erschienen am 29.10.2025. Verfasst von Yi-Ting Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to evaluate the efficacy of platelet-rich plasma (PRP) in treating knee osteoarthritis (KOA) and the effects of baseline characteristics and PRP intervention parameters on treatment outcomes.
Methods
Overall, 140 individuals diagnosed with KOA who received PRP injections and completed a 6-month follow-up period were enrolled in this retrospective analysis. Knee pain and functional outcomes were assessed using the Visual Analog Scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Based on the Minimal Clinically Important Difference (MCID) in outcomes, the participants were divided into effective and ineffective groups. Using multivariable logistic regression to explore factors influencing treatment outcomes, we compared the effective and ineffective groups to identify predictors of response to PRP therapy.
Results
At 6 months, the median (IQR) VAS score significantly decreased from 66.5 (27) to 24 (34) (95% CI = −38 to −30.5), p < 0.001), and WOMAC scores improved from 29 (22) to 12 (14) (95% CI = −16.5 to −12), p < 0.001). Five mild adverse events were reported. Multivariate analysis indicated that only the number of injections significantly influenced VAS outcomes (OR = 4.285, 95% CI: 1.586–11.578, p = 0.004). Regarding WOMAC, multivariate analysis revealed that body mass index (BMI) (OR = 0.867, 95% CI: 0.755–0.995, p = 0.042) and disease duration (OR = 0.905, 95% CI: 0.784–0.989, p = 0.045) significantly affected outcomes. Age, sex, Kellgren-Lawrence (KL) grade, number of PRP injections, and injection frequency did not significantly impact WOMAC scores.
Conclusion
PRP therapy is a safe and effective treatment option for KOA. In this 6-month follow-up investigation, we observed that the number of injections administered affected pain levels, while disease duration and BMI affected knee joint function. Insights from this study may facilitate patient selection and PRP treatment protocol optimization in clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rehabilitation Medicine Center and Institute of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, China.
- School of Rehabilitation Sciences, West China School of Medicine, Sichuan University, Chengdu, China.
- Key Laboratory of Rehabilitation Medicine in Sichuan Province, West China Hospital, Sichuan University, Chengdu, China.
- Department of Rehabilitation Medicine, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Zitieren
APA
Sun, Y. T., Xiang, X. N., Yang, J., Peng, J. L., & He, H. C. (2025). Platelet-rich plasma improves pain and function in knee osteoarthritis: a retrospective study. Frontiers in Physiology, 16. https://doi.org/10.3389/fphys.2025.1678037
Vancouver
Sun YT, Xiang XN, Yang J, Peng JL, He HC. Platelet-rich plasma improves pain and function in knee osteoarthritis: a retrospective study. Frontiers in Physiology. 2025;16. doi:10.3389/fphys.2025.1678037
BibTeX
@article{Sun2025,
author = {Sun, Yi-Ting and Xiang, Xiao-Na and Yang, Jie and Peng, Jia-Lei and He, Hong-Chen},
title = {Platelet-rich plasma improves pain and function in knee osteoarthritis: a retrospective study},
journal = {Frontiers in Physiology},
year = {2025},
volume = {16},
doi = {10.3389/fphys.2025.1678037}
}
EUVIMED